Publications directory

Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm

The web Directory of Information Materials for People Affected by Cancer is regularly updated and currently has details of over 1,900 booklets, leaflets, books and audiovisual materials for people affected by cancer. Most have been published in the last five years but we have included some older ones that are still useful.

Results: 246

Cover image of 'Paclitaxel and carboplatin [Chinese, Traditional]'

Paclitaxel and carboplatin [Chinese, Traditional] (2020)

Macmillan Cancer Support

Paclitaxel (Taxol®) and carboplatin is a combination chemotherapy regime used to treat cancer of the ovary and cancer of the lung. This factsheet describes the drugs, how they are given and the possible side-effects.

Cover image of 'Chemotherapy regimens for lymphoma'

Chemotherapy regimens for lymphoma (February 2020)

Lymphoma Action

This information sheet is about chemotherapy regimens (combinations of drugs) for lymphoma. It covers: What is a chemotherapy regimen?; Common chemotherapy regimens for lymphoma; Which chemotherapy regimen might I have?; Side effects of chemotherapy regimens. Includes a list of the most common chemotherapy regimens for lymphoma. 

Cover image of 'FLAG-Ida for acute myeloid leukaemia (AML). A guide for patients'

FLAG-Ida for acute myeloid leukaemia (AML). A guide for patients (January 2020)

Leukaemia Care

FLAG-Ida is a combination chemotherapy regimen used in the treatment of acute myeloid leukaemia (AML). It consists of fludarabine, high dose cytarabine (Ara-C0), idarubicin and granulocyte-colony stimulating factor (G-CSF). This booklet explains the drugs, who may be eligible to receive this treatment, how FLAG-Ida is given, and the possible side-effects. Includes a glossary and details of further support and information.

Cover image of 'FEC-T chemotherapy'

FEC-T chemotherapy (February 2019)

Breast Cancer Care

This booklet explains what the chemotherapy combination FEC-T is, when it may be prescribed, how it is given and what side effects may occur. FEC-T is a combination of four chemotherapy drugs: 5 fluorouracil (also known as 5FU); epirubicin; cyclophosphamide; docetaxol (also known as Taxotere).

Cover image of 'FEC chemotherapy'

FEC chemotherapy (February 2019)

Breast Cancer Care

This leaflet describes the FEC chemotherapy combination (5 fluorouracil, epirubicin and cyclophosphamide), when it may be used, how it works, how it is given and the possible side-effects.

Cover image of 'R-CHOP chemotherapy [Slovak]'

R-CHOP chemotherapy [Slovak] (October 2019)

Macmillan Cancer Support

R-CHOP is a combination treatment used to treat non-Hodgkin lymphoma (NHL). This factsheet describes the drugs used, how they are given and the possible side-effects.

Cover image of 'XELOX (or CAPOX) [Lithuanian]'

XELOX (or CAPOX) [Lithuanian] (2019)

Macmillan Cancer Support

XELOX (or CAPOX) may be used to treat advanced bowel cancer. This factsheet describes the drugs used, how they are given and some of the possible side-effects.

Cover image of 'XELOX (or CAPOX) [Chinese, Traditional]'

XELOX (or CAPOX) [Chinese, Traditional] (2019)

Macmillan Cancer Support

XELOX (or CAPOX) may be used to treat advanced bowel cancer. This factsheet describes the drugs used, how they are given and some of the possible side-effects.

Cover image of 'GemCarbo chemotherapy [Vietnamese]'

GemCarbo chemotherapy [Vietnamese] (June 2018)

Macmillan Cancer Support

GemCarbo is a combination chemotherapy treatment that is used to treat several types of cancer, but most commonly lung cancer. This factsheet describes the drugs, how they are given and the possible side-effects.

Cover image of 'R-CHOP chemotherapy [Romanian]'

R-CHOP chemotherapy [Romanian] (October 2018)

Macmillan Cancer Support

R-CHOP is a combination treatment used to treat non-Hodgkin lymphoma (NHL). This factsheet describes the drugs used, how they are given and the possible side-effects.

Cover image of 'EOX chemotherapy [Thai]'

EOX chemotherapy [Thai] (2018)

Macmillan Cancer Support

EOX chemotherapy is used to treat oesophageal cancer and stomach cancer. This factsheet describes the drugs used (epirubicin, oxaliplatin and capecitabine), how the treatment is given and the possible side-effects.

Cover image of 'GemCis chemotherapy [Russian]'

GemCis chemotherapy [Russian] (June 2018)

Macmillan Cancer Support

This is a translation of information from the Macmillan Cancer Support website. It describes the GemCis chemotherapy regimen to treat many cancers, the drugs, how treatment is given, and possible side-effects.

Cover image of 'GemCis chemotherapy [Turkish]'

GemCis chemotherapy [Turkish] (June 2018)

Macmillan Cancer Support

This is a translation of information from the Macmillan Cancer Support website. It describes the GemCis chemotherapy regimen to treat many cancers, the drugs, how treatment is given, and possible side-effects.

Cover image of 'GemCis chemotherapy [Polish]'

GemCis chemotherapy [Polish] (June 2018)

Macmillan Cancer Support

This is a translation of information from the Macmillan Cancer Support website. It describes the GemCis chemotherapy regimen to treat many cancers, the drugs, how treatment is given, and possible side-effects.

Cover image of 'ABVD [Bulgarian]'

ABVD [Bulgarian] (May 2018)

Macmillan Cancer Support

Information from the Macmillan Cancer Support website translated into Bulgarian. ABVD chemotherapy is a combination treatment used to treat Hodgkin Lymphoma. This factsheet describes what it is, how it is given, and possible side effects.

Cover image of 'DA (Daunarubicin) and ARAc for acute myeloid leukaemia. A guide for patients'

DA (Daunarubicin) and ARAc for acute myeloid leukaemia. A guide for patients (December 2018)

Leukaemia Care

This booklet describes DA treatment, a combination of the drugs daunorubicin and cytarabine (Ara-C), used primarily as induction chemotherapy in patients with newly diagnosed acute myeloid meukaemia. It describes how DA is given, and the possible side-effects. Includes a glossary and details of further support and information.

Cover image of 'Future treatments in acute myeloid leukaemia (AML). A guide for patients'

Future treatments in acute myeloid leukaemia (AML). A guide for patients (October 2018)

Leukaemia Care

The main treatment for acute myeloid leukaemia (AML) is chemotherapy, including targeted therapy. This might be followed by a stem cell transplant, and surgery and radiotherapy may be used in special circumstances. New therapies are being developed and investigated and this booklet describes several of these: clofarabine (DNA synthesis inhibitor); gilteritinib and quizartinib (tyrosine kinase inhibitors); venetoclax (B-cell lymphoma-2 (BCL2) inhibitor); and Vyxeos® (a combination of daunorubicin and cytarabine. 

Cover image of 'FEC chemotherapy [Arabic]'

FEC chemotherapy [Arabic] (2017)

Macmillan Cancer Support

FEC is a combination chemotherapy treatment for breast cancer. This factsheet describes the drugs, how they are given and some of the possible side-effects.

Cover image of 'FEC chemotherapy [Portuguese]'

FEC chemotherapy [Portuguese] (September 2017)

Macmillan Cancer Support

FEC is a combination chemotherapy treatment for breast cancer. This factsheet describes the drugs, how they are given and some of the possible side-effects.

Cover image of 'FEC-T chemotherapy [Polish]'

FEC-T chemotherapy [Polish] (2017)

Macmillan Cancer Support

This information describes the FEC-T chemotherapy regimen, which is used to treat breast cancer. It describes the drugs used, how treatment is given, and some of the possible side-effects.

Cover image of 'FEC-T chemotherapy [Romanian]'

FEC-T chemotherapy [Romanian] (September 2017)

Macmillan Cancer Support

This information describes the FEC-T chemotherapy regimen, which is used to treat breast cancer. It describes the drugs used, how treatment is given, and some of the possible side-effects.

Cover image of 'EC chemotherapy [Latvian]'

EC chemotherapy [Latvian] (2017)

Macmillan Cancer Support

The EC chemotherapy regime (epirubicin and cyclophosphamide) is used to treat breast cancer. This factsheet describes how this combination is given and the possible side-effects.

Cover image of 'Vinorelbine and cisplatin chemotherapy [Chinese, Traditional]'

Vinorelbine and cisplatin chemotherapy [Chinese, Traditional] (November 2017)

Macmillan Cancer Support

Vinorelbine and cisplatin may be used to treat non-small-cell lung cancer. This factsheet describes what it is, how the drugs are given and the possible side-effects.

Cover image of 'BEAM chemotherapy [Punjabi]'

BEAM chemotherapy [Punjabi] (November 2017)

Macmillan Cancer Support

This information from the Macmillan Cancer Support website has been translated into Punjabi. BEAM is a combination chemotherapy treatment used to treat Hodgkin lymphoma and non-Hodgkin lymphoma. It is given before a stem cell transplant. It may also be used to treat other cancers. This factsheet describes what it is, how it is given, and possible side effects.

Cover image of 'FOLFIRINOX'

FOLFIRINOX (May 2017)

Pancreatic Cancer UK

FOLFIRINOX is a possible treatment option for advanced pancreatic cancer. It is a combination of four drugs (leucovorin (folinic acid), fluorouracil, irinotecan and oxaliplatin). This factsheet describes how it is given and the possible side effects.

Cover image of 'DT-PACE'

DT-PACE (November 2017)

Myeloma UK

DT-PACE is a treatment combination used to treat myeloma patients who have received several previous treatments or who are refractory to treatment. This factsheet describes what it is, how it works, how it is given, and possible side-effects.

Cover image of 'Prostate cancer information booklet'

Prostate cancer information booklet (January 2020)

PCaSO Prostate Cancer Support Network

This booklet covers diagnosis (including the DRE and the PSA test), the Gleason score and the staging of prostate cancer, treatment options (active surveillance, watchful waiting, radical prostatectomy, external beam radiotherapy, brachytherapy, cryotherapy, high intensity focused ultrasound, hormone treatment, chemotherapy and photodynamic therapy), clinical trials, side effects (sexual problems, continence, bone health), and diet and lifestyle.

Cover image of 'Capecitabine (Xeloda®) [Polish]'

Capecitabine (Xeloda®) [Polish] (January 2020)

Macmillan Cancer Support

Capecitabine is given as a treatment for many types of cancer including colorectal cancer, breast cancer, oesophageal cancer, pancreatic cancer and stomach cancer. This factsheet describes how it is given and some of the possible side-effects.

Cover image of 'Hydroxycarbamide (Hydrea®) [Bulgarian]'

Hydroxycarbamide (Hydrea®) [Bulgarian] (2020)

Macmillan Cancer Support

Hydroxycarbamide (also known as hydroxyurea) is used to treat chronic myeloid leukaemia, cervical cancer, and some pre-cancerous conditions. This factsheet describes how it is given and the possible side-effects.

Cover image of 'Docetaxel (Taxotere)'

Docetaxel (Taxotere) (October 2020)

Breast Cancer Now

This factsheet explains briefly what Taxotere® is, when it may be prescribed, how it works, the benefits, and possible side-effects.

Cover image of 'My chemotherapy journey'

My chemotherapy journey (2020)

Ken Harwood

The author was diagnosed in 2019 with a low-grade non-Hodgkin lymphoma and this is his day-by-day account of his chemotherapy journey over a six month period.

Cover image of 'Understanding colon cancer'

Understanding colon cancer (April 2020)

Macmillan Cancer Support

This booklet is about colon cancer. The colon is part of the bowel. We have separate information about small bowel cancer, rectal cancer and anal cancer. The booklet explains what colon cancer is, and how it is diagnosed and treated. It also talks about your feelings when you are diagnosed with cancer and has practical advice on dealing with work and finances. When we mention bowel cancer in this booklet, this includes colon cancer.  

Cover image of 'Understanding primary liver cancer. Hepatocellular carcinoma or hepatoma'

Understanding primary liver cancer. Hepatocellular carcinoma or hepatoma (June 2020)

Macmillan Cancer Support

This booklet is about the most common type of primary liver cancer, hepatocellular carcinoma (HCC). It is for anyone who has been diagnosed with primary liver cancer. There is also information for carers, family members and friends. The booklet talks about the signs and symptoms of primary liver cancer. It explains how it is diagnosed and how it may be treated. It also has information about controlling symptoms and coping with emotional, practical and financial issues. 

Cover image of 'Understanding secondary cancer in the liver'

Understanding secondary cancer in the liver (June 2020)

Macmillan Cancer Support

This booklet is about secondary cancer in the liver. This is cancer that has spread to the liver from somewhere else in the body. It is for anyone who has been diagnosed with secondary cancer in the liver. There is also information for carers, family members and friends. The booklet talks about the signs and symptoms of secondary cancer in the liver. It explains how it is diagnosed and how it may be treated. It also has information about controlling symptoms and coping with emotional, practical and financial issues. 

Cover image of 'Eating – help yourself. A guide for patients and their carers'

Eating – help yourself. A guide for patients and their carers (February 2019)

Christie Hospital NHS Trust

Eating may be a problem for people with cancer or other illnesses, particularly when undergoing treatment such as radiotherapy or chemotherapy. This booklet has advice on how to eat well when trying to cope with loss of appetite, changes in taste, dry mouth, difficulties swallowing, feeling full, nausea, diarrhoea, and constipation. It has tips on how to make food as nourishing as possible and ideas for snacks and drinks.

Cover image of 'Chemotherapy for lung cancer'

Chemotherapy for lung cancer (February 2019)

Roy Castle Lung Cancer Foundation

This booklet was produced in partnership with lung cancer experts and people affected by lung cancer to help you make positive, informed choices about your care and treatment.

Cover image of 'Understanding your small cell lung cancer'

Understanding your small cell lung cancer (February 2019)

Roy Castle Lung Cancer Foundation

This booklet explains what small cell lung cancer is, and addresses common questions and concerns. 

Cover image of 'Radiotherapy and chemotherapy (for non localised cancer)'

Radiotherapy and chemotherapy (for non localised cancer) (March 2019)

Orchid – Fighting Male Cancer

This leaflet describes the use of radiotherapy and chemotherapy to treat cancer that has spread beyond the penis to other parts of the body.

Cover image of 'Chemotherapy'

Chemotherapy (November 2019)

Orchid – Fighting Male Cancer

This leaflet describes how chemotherapy may be used to treat localised and non-localised testicular cancer, and the possible side-effects..

Cover image of 'Chemotherapy for pancreatic cancer'

Chemotherapy for pancreatic cancer (August 2019)

Pancreatic Cancer UK

This fact sheet is for anyone who wants to know more about treating pancreatic cancer with chemotherapy. It explains how chemotherapy is given, and the different drugs that may be used. It also explains the main side effects of chemotherapy and how these can be managed and how to look after yourself and get support during chemotherapy.. 

Cover image of 'Melphalan'

Melphalan (January 2019)

Myeloma UK

Melphalan is a chemotherapy drug used in the treatment of myeloma. It belongs to a class of chemotherapy drugs called alkylating agents.This factsheet describes what it is, how it works, how it is given, and possible side-effects.

Cover image of 'Newly diagnosed pack'

Newly diagnosed pack (2019)

Pancreatic Cancer UK

The newly diagnosed pack is for people recently diagnosed with pancreatic cancer. It contains the following publications: An overview of diagnosis and treatment, Diet and pancreatic cancer, Chemotherapy for pancreatic cancer, We're here for you leaflet and our Patient Charter. Depending on your situation we will also include: Surgery for operable pancreatic cancer, Stents and bypass surgery or Caring for someone with pancreatic cancer. 

Cover image of 'Adrenocortical carcinoma - AAC. Patient information for adult patients'

Adrenocortical carcinoma - AAC. Patient information for adult patients (October 2019)

Adrenocortical Cancer Support and Information

Guidance for people with adrenocortical carcinoma (AAC). Describes what AAC is, its symptoms, diagnosis, and treatment options.

Cover image of 'Dexamethasone'

Dexamethasone (January 2019)

Myeloma UK

Dexamethasone is a steroid drug used in the treatment of myeloma. It belongs to a class of steroids called glucocorticoids. This factsheet describes what it is, how it works, how it is given, and possible side-effects.

Cover image of 'Bendamustine'

Bendamustine (January 2019)

Myeloma UK

Bendamustine is an alkylating agent that may be used to treat people with myeloma. This factsheet describes what it is, how it works, how it is given, and possible side-effects.

Cover image of 'Understanding breast cancer in women [Audio CD]'

Understanding breast cancer in women [Audio CD] (January 2019)

Macmillan Cancer Support

Audio CD of the booklet, which describes the causes, symptoms, diagnosis, stages, and treatment of breast cancer including surgery, radiotherapy, chemotherapy and hormonal therapy. It also discusses issues such as fertility, hormone replacement therapy, and feelings. Includes details of useful organisations and other resources such as books and websites.

Cover image of 'Melflufen (Ygalo®)'

Melflufen (Ygalo®) (December 2019)

Myeloma UK

Melflufen is a new drug being investigated in the treatment of myeloma. It is a derivative of the chemotherapy drug melphalan. This factsheet explains what melflufen is, how it works, and the current evidence to support its use in the treatment of myeloma. It also describes the known possible side-effects, and the availability of melflufen in the UK.

Cover image of 'Peripheral neuropathy'

Peripheral neuropathy (April 2019)

Lymphoma Action

Peripheral neuropathy may be a side-effect of chemotherapy. This factsheet describes peripheral neuropathy, the chemotherapy drugs that most commonly cause it, the symptoms and diagnosis, reducing the risk and managing the symptoms.

Cover image of 'Reduced fertility'

Reduced fertility (April 2019)

Lymphoma Action

This factsheet gives an overview of the risks to fertility associated with common lymphoma treatments. It outlines methods to help preserve fertility before treatment. Topics include: chemotherapy and fertility; radiotherapy and fertility; targeted therapies and fertility; preserving fertility; planning a family after lymphoma treatment; ways to help you conceive if you have fertility difficulties; emotional support; useful resources and organisations

Cover image of 'Cyclophosphamide'

Cyclophosphamide (January 2019)

Myeloma UK

Cyclophosphamide is a chemotherapy drug used in the treatment of myeloma. It belongs to a class of chemotherapy drugs called alkylating agents. This factsheet describes what it is, how it works, how it is given, and possible side-effects.

Sorry, no publications found.
Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm